Loading...

PacificHealth Laboratories, Inc.

PHLIPNK
Consumer DefensiveHousehold & Personal Products
$0.00
$0.00(9900.00%)

PacificHealth Laboratories, Inc. PHLI Peers

See (PHLI) competitors and their performances in Stock Market.

Peer Comparison Table: Household & Personal Products Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PHLI$0.00+9900.00%438307.00N/AN/AN/A
LRLCY$86.20-1.91%230.29B31.93$2.70+1.39%
LRLCF$427.40-4.26%228.37B31.59$13.53+1.85%
UNLYF$62.98+5.05%157.51B24.32$2.59+3.02%
RBGPF$63.81N/A43.49B23.55$2.71+4.09%
RBGLY$12.75-0.47%43.45B23.61$0.54+4.10%
HELKF$72.01-3.95%31.53B13.31$5.41+2.85%
HENOY$19.76+1.13%31.42B14.64$1.35+2.23%
HENKY$17.75+0.06%30.99B13.15$1.35+2.45%
BDRFF$138.46+11.12%30.91B30.23$4.58+0.82%
Showing 1 to 10 of 99 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PHLI vs LRLCY Comparison

PHLI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PHLI stands at 438307.00. In comparison, LRLCY has a market cap of 230.29B. Regarding current trading prices, PHLI is priced at $0.00, while LRLCY trades at $86.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PHLI currently has a P/E ratio of N/A, whereas LRLCY's P/E ratio is 31.93. In terms of profitability, PHLI's ROE is -0.54%, compared to LRLCY's ROE of +0.21%. Regarding short-term risk, PHLI is more volatile compared to LRLCY. This indicates potentially higher risk in terms of short-term price fluctuations for PHLI.

Stock Price Comparison

Loading...

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.